Antimicrobial and antiviral agents

Macrolides: Significance and Safety for the Treatment of Pneumonia
The incidence of bacterial conjunctivitis and the antibacterial activity of drugs in their treatment
Published in the journal «Ophthalmology. Eastern Europe» Vol 9 № 4’2019
Antibiotic therapy in the time of multidrug resistance: a great future for fosfomycin
Published in the medical newspaper «Health of Ukraine of the 21st century» № 15-16 (460-461)’2019
Combined urogenital infection and features of its treatment
Published in the journal «Medical Aspects of Men's Health» № 3 (30)’2018
Antibiotic therapy in pregravid preparation of women at risk of intrauterine infection
Published in a journal «Women's Health» № 10 (126)’2017
The combination of Levoximed and Secnidox drugs in the treatment of pelvic inflammatory disease (PID)
Published in a journal «Women's Health» № 7 (113)’2016
Some aspects of the use of fosfomycin in the treatment of postcoital cystitis in the practice of a dermatovenerologist
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 1 (76)’2020
The use of fosfomycin trometamol in modern clinical practice
Published in the journal «Ukrainian Journal of Perinatology and Pediatrics» № 1 (81)’2020
The optimal approach to the complex treatment of mixed urinary tract infections
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 1 (76)’2020
Close relationship: vegetative homeostasis, biocenosis, reproductive potential
Published in the journal «Health of Ukraine» № 1 (25)’2017

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design